Talk:Androgen receptor
Jump to navigation
Jump to search
AR IHC in prostate ca: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433029/
AR IHC in breast carcinoma that looked at the response to enzalutamide - https://ascopubs.org/doi/full/10.1200/PO.17.00075 ( Androgen Receptor Immunohistochemistry as a Companion Diagnostic Approach to Predict Clinical Response to Enzalutamide in Triple-Negative Breast Cancer ) ; they used a cut-off of 10% nuclear staining.